Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients

por Nätynki, Antti, Leisti, Päivi, Tuusa, Jussi, Varpuluoma, Outi, Huilaja, Laura, Izumi, Kentaro, Herukka, Sanna-Kaisa, Ukkola, Olavi, Junttila, Juhani, Kokkonen, Nina, Tasanen, Kaisa
Publicado 2022